🔎 Trials Near Me

Akèy › Skleroz Amiotrofik Lateral › Texas › Dallas

Etid klinik pou Skleroz Amiotrofik Lateral nan Dallas, TX

8 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System

Ap rekrite
  • UT Southwestern Medical Center, Dallas
Laj 18 a 65 · Tout sèks · Mizajou Oct 1, 2026 · NCT05936619

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Ap rekriteFaz 3
  • Texas Neurology, Dallas
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Ap rekriteFaz 2
  • Zydus US001, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07023835

ASSESS ALL ALS Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Texas Neurology, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195

PREVENT ALL ALS Study

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Texas Neurology, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861

Study of COYA 302 for the Treatment of ALS

Ap rekriteFaz 2/3
  • Texas Neurology, PA, Dallas
Laj 18 a 80 · Tout sèks · Mizajou Aug 6, 2026 · NCT07161999

INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study

Ap rekrite
  • University of Texas Southwestern Medical Center (UTSW), Dallas
Laj 22 ak plis · Tout sèks · Mizajou May 11, 2026 · NCT07543367

VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration

Ap rekrite
  • The University of Texas Southwestern Medical Center, Dallas
Laj 22 a 75 · Tout sèks · Mizajou Nov 4, 2025 · NCT07224256

Etid Skleroz Amiotrofik Lateral nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.